Alembic Pharma’s India and US segments contribute 35 per cent and 26 per cent, respectively, to its total revenue. Founded in 1907, the company makes drugs like Azithral, used to treat bacterial infections, and anti-ulcer medicine Deltone, besides active pharmaceutical ingredients (API) for acute and chronic diseases.
